Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease
A family is described as having two recessively inherited metabolic diseases and three differently affected children. During the explantation of a drain tube grommet under general anesthesia, a prolonged resuscitation and wake-up period occurred in the key case when he was 8 years old. This led to a...
Main Authors: | Max Arslan, Max Novak, Dietmar Rosenthal, Christian J. Hartmann, Philipp Albrecht, Sara Samadzadeh, Harald Hefter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/10/1398 |
Similar Items
-
Pseudocholinesterase as a Biomarker for Untreated Wilson’s Disease
by: Harald Hefter, et al.
Published: (2022-11-01) -
Differences in the Time Course of Recovery from Brain and Liver Dysfunction in Conventional Long-Term Treatment of Wilson Disease
by: Harald Hefter, et al.
Published: (2023-07-01) -
Analysis of Running in Wilson’s Disease
by: Sara Samadzadeh, et al.
Published: (2022-01-01) -
Mildly Impaired Foot Control in Long-Term Treated Patients with Wilson’s Disease
by: Sara Samadzadeh, et al.
Published: (2021-12-01) -
Analysis of Single-Leg Hopping in Long-Term Treated Patients with Neurological Wilson’s Disease: A Controlled Pilot Study
by: Harald Hefter, et al.
Published: (2022-02-01)